Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.98B | 7.55B | 7.54B | 7.58B | 6.49B | 4.21B | Gross Profit |
3.11B | 2.97B | 2.96B | 2.99B | 2.57B | 1.59B | EBIT |
940.19M | 709.37M | 969.33M | 1.16B | 981.07M | 286.00M | EBITDA |
1.24B | 1.13B | 1.38B | 1.56B | 1.31B | 580.79M | Net Income Common Stockholders |
651.16M | 435.09M | 727.45M | 868.11M | 694.10M | 222.31M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.20B | 4.81B | 4.34B | 3.97B | 5.94B | 5.03B | Total Assets |
12.28B | 12.60B | 12.15B | 11.70B | 11.92B | 10.63B | Total Debt |
653.00M | 744.23M | 509.84M | 649.82M | 1.40B | 1.56B | Net Debt |
-3.55B | -4.07B | -3.83B | -3.32B | -4.54B | -3.47B | Total Liabilities |
1.86B | 2.25B | 1.99B | 2.19B | 3.13B | 2.39B | Stockholders Equity |
10.33B | 10.27B | 10.06B | 9.43B | 8.72B | 8.17B |
Cash Flow | Free Cash Flow | ||||
0.00 | 756.20M | 802.00M | -1.04B | 1.19B | -419.47M | Operating Cash Flow |
0.00 | 917.74M | 1.14B | -282.73M | 1.34B | -311.06M | Investing Cash Flow |
0.00 | -401.12M | -330.75M | -753.22M | -140.84M | -108.41M | Financing Cash Flow |
0.00 | -12.16M | -513.63M | -958.97M | -333.69M | 563.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥5.40B | 5.19 | 2.38% | 11.07% | 34.17% | ||
74 Outperform | ¥5.71B | 13.22 | 4.07% | 0.20% | -40.38% | ||
69 Neutral | ¥9.60B | 10.92 | 0.55% | 9.79% | -25.96% | ||
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% | |
61 Neutral | ¥5.06B | ― | 2.15% | -2.05% | -14.82% | ||
54 Neutral | ¥5.04B | ― | 1.90% | 10.20% | -142.31% |